Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-012571

Chief Scientific Officer sold 115,250 shares at an average $46.15 ($5,318,769)

  • Chief Scientific Officer acquired 115,250 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Zago Wagner M. · Chief Scientific Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-22 Exercise or conversion : show line 1 in the form +15,000 $20.17 $302,550 15,000 D
2021-06-22 Exercise or conversion : show line 2 in the form +19,000 $27.81 $528,390 34,000 D
2021-06-22 Exercise or conversion : show line 3 in the form +81,250 $15.04 $1,222,000 115,250 D
2021-06-22 Sale : show line 4 in the form −65,840 $45.42 $2,990,249 49,410 D
2021-06-22 Sale : show line 5 in the form −26,106 $46.27 $1,208,037 23,304 D
2021-06-22 Sale : show line 6 in the form −18,101 $47.81 $865,498 5,203 D
2021-06-22 Sale : show line 7 in the form −5,203 $49.01 $254,986 0 D
Open-market sales · 115,250 sh · avg $46.15 · $5,318,769

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-06-22 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −15,000 $20.17 2023-09-03 15,000 0 D
2021-06-22 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −19,000 $27.81 2025-03-11 19,000 0 D
2021-06-22 Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) −81,250 $15.04 2028-06-21 81,250 68,750 D
Loading xslF345X03/doc1.xml…